A novel DP2receptor antagonist (AM-461): a patent evaluation of WO2011085033

Discovery and optimization of a biphenylacetic acid series of prostaglandin D2 receptor DP2 antagonists with efficacy in a murine model of allergic rhinitis

(2011) Jill M. Scott et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists—discovery of AZD1981

(2011) Tim Luker et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Pharmacology of AM211, a Potent and Selective Prostaglandin D2 Receptor Type 2 Antagonist That Is Active in Animal Models of Allergic Inflammation

(2011) G. Bain et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation

(2010) Karin J. Stebbins et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

DP2receptor antagonists in development

(2010) Peter Norman   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Novel CRTH2 antagonists: a review of patents from 2006 to 2009

(2010) Trond Ulven et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitis

(2009) Brian A. Stearns et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Pharmacological Blockade of the DP2 Receptor Inhibits Cigarette Smoke-Induced Inflammation, Mucus Cell Metaplasia, and Epithelial Hyperplasia in the Mouse Lung

(2009) K. J. Stebbins et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS